EANS-Adhoc: november AG
Capital increase announced by november
Aktiengesellschaft
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement.
11.11.2009
The Management Board of november Aktiengesellschaft has decided today with the consent of the Supervisory Board to partially use the authorized capital according to § 5 of the Articles of Incorporation and to increase the nominal capital of the corporation from EUR 4.680.505,00 by max. EUR 1.560.168,00 to max. EUR 6.240.673,00 by issuing up to 1.560.168 new no-par bearer shares against cash deposit at the issue price of EUR 1,00 per share. Shareholders are granted legal subscription rights on the new shares. The new shares are offered to the shareholders at a ratio of 3:1. The subscription right cannot be traded. Subscription right for fractional shares is excluded. For calculatory purposes, the corporation has taken provisions that the subscription right from one share is not exercised. Issuing institute is VEM Aktienbank AG, Munich. VEM is accredited take-over and trading admission of the new shares.
It is the intent of the november Aktiengesellschaft to strengthen with this capital increase its equity base and to create additional financial flexibility for future growth.
end of announcement euro adhoc
Further inquiry note:
Dr. Dirk Zurek
Vorstand
Tel.: +49 (0) 221 82200 520 20
E-Mail: dzurek@november.de
Branche: Biotechnology
ISIN: DE000A0Z24E9
WKN: A0Z24E
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Stuttgart / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade